Wednesday, December 3rd 2014
Print this page
The Consortium will be represented at this week's British Thoracic Society's Winter Meeting in London.
Four Abstracts are being presented, 3 are based on background work to our Multi-Dose clinical trial and one is based on our ongoing development of a Lentiviral Vector for CF Lung Disease.
Gl67A Mixing Device (2009): Mixing device developed by the Consortium to reproducibly mix GL67A and pGM169 for the clinical trial. More...